期刊文献+

80例肺癌患者伴肺部感染的痰培养与药敏试验结果分析 被引量:6

下载PDF
导出
摘要 目的:分析晚期肺癌合并肺部感染患者的病菌病原学情况,为临床使用抗茵药物提供依据。方法:回顾性分析2004年2月~2006年2月本院收治的合并肺部感染的肺癌患者的病菌病原学及药敏资料。结果:肺癌合并肺部感染的病原体以G-杆菌为主(占58.2%),包括肺炎克雷伯菌、铜绿假单胞菌、大肠埃希菌等;其次为革兰阳性球菌,分别为金黄色葡萄球菌、溶血葡萄球菌、肠球菌等;真菌居第3位。结论:晚期肺癌合并肺部感染以G-杆菌为主。合并真菌感染也比较常见。
出处 《中国当代医药》 2011年第21期112-113,共2页 China Modern Medicine
  • 相关文献

参考文献5

二级参考文献14

  • 1Andrew J. Hope,Patricia E. Lindsay,Issam El Naqa,James R. Alaly,Milos Vicic,Jeffrey D. Bradley,Joseph O. Deasy.Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters[J].International Journal of Radiation Oncology Biology Physics.2006(1)
  • 2Daniel T. Chang,Kenneth R. Olivier,Christopher G. Morris,Chihray Liu,James F. Dempsey,Rashmi K. Benda,Jatinder R. Palta.The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis[J].International Journal of Radiation Oncology Biology Physics.2006(1)
  • 3Mary V Graham,James A Purdy,Bahman Emami,William Harms,Walter Bosch,Mary Ann Lockett,Carlos A Perez.Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)[J].International Journal of Radiation Oncology Biology Physics.1999(2)
  • 4Emami B,Lyman J,Brown A,et al.Tolerance of normal tissue to therapeutic irradiation[].International Journal of Radiation Oncology Biology Physics.1991
  • 5Brambilla C,Romand P,Vanderkerckhove C,et al.Respiratory infection and bronchial cancer[].Revue des Maladies Respiratoires.1992
  • 6Nagata N,Ishibashi T,Shigenatsu N,et al.Autopsy cases of terminal pulmonary infections[].Nippon Kyobu Shikkan Gakkai.1989
  • 7Nagatomo T,Watanabe K,Kunikane H,et al.A randomized controlled trial of sulfamethoxazole trimethoprim plus norfloxacin versus sulfamerthoxazole trimethoprim alone for the prophylaxis of bacterial infection during chemotherapy for lung cancer[].Lung Cancer.1998
  • 8Watanbe A,Nakai Y,Saito J,et al.Clinical significance of respiratory associated with lung cancer patients[].Japanese Journal of Thoracic Diseases.1992
  • 9Slupek A,Podsiadlo B,Augustynowica-Kopec E.Pulmonary infections in patients with lung cancer during antineoplastic therapy[].Pneumonologia i Alergologia Polska.1993
  • 10Kohno S,Koga H,Oka M,et al.The pattern of respiratory infection in patients with lung cancer[].Tohoku Journal of Experimental Medicine.1994

共引文献12

同被引文献54

  • 1胡凯文,王芬,左明焕,肖俐,曹阳,何秀兰,陈文强.中晚期肺癌患者合并肺部细菌感染的中医证候危险因素分析[J].中国中医基础医学杂志,2004,10(8):45-46. 被引量:10
  • 2王春全.痰热清注射液的方解及功效[J].现代医药卫生,2006,22(5):720-720. 被引量:28
  • 3葛涵,沈舜义.大环内酯类抗生素研究进展[J].世界临床药物,2007,28(6):376-380. 被引量:28
  • 4陈灏珠,主编.实用内科学[M]第12版.北京:人民卫生出版社,2005.1 231-1 245.
  • 5李金祥.姑息医学[M].成都:四川科技出版社,2009:147.
  • 6Wren SM, Martin M, Yoon JK, et al. Postoperative pneumonia-prevention program for the inpatient surgical ward. J Am Coil Surg, 2010, 210 (4): 491-495.
  • 7Yamada Y, Sekine Y, Suzuki H, et al. Trends of bacterial colonisa- tion and the risk of postoperative pneumonia in lung cancer patients with chronic obstructive pulmonary disease. Eur J Cardiothorac Surg, 2010, 37 (4): 752-757.
  • 8Alifano M, Regnard JF. Postoperative pneumonia in lung cancer patients: chronic obstructive pulmonary disease, preoperative bronchial colonisation and antibioprophylaxis are critical issues. Eur J Cardiothorac Surg, 2010, 37 (4): 750-751.
  • 9Strand TE, Rostad H, Damhuis RA, et al. Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude. Thorax, 2007, 62 ( 11 ) : 991-997.
  • 10CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI document M100-S21. Wayne, PA: Clinical and laboratory standards institute, 2011.

引证文献6

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部